ID
12801
Description
Alemtuzumab and Clofarabine for Relapsed or Refractory Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT00983528
Lien
https://clinicaltrials.gov/show/NCT00983528
Mots-clés
Versions (1)
- 21/12/2015 21/12/2015 -
Téléchargé le
21 décembre 2015
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Acute Lymphoblastic Leukemia NCT00983528
Eligibility Acute Lymphoblastic Leukemia NCT00983528
- StudyEvent: Eligibility
Description
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Description
current concomitant chemotherapy, radiation therapy, or immunotherapy
Type de données
boolean
Alias
- UMLS CUI [1]
- C0392920
- UMLS CUI [2]
- C1522449
- UMLS CUI [3]
- C0021083
Description
study subject participation status
Type de données
boolean
Alias
- UMLS CUI [1]
- C2348568
Description
cns or testicular only relapse
Type de données
boolean
Alias
- UMLS CUI [1]
- C0277556
- UMLS CUI [2]
- C3714787
- UMLS CUI [3]
- C0039590
Description
Comorbidity
Type de données
boolean
Alias
- UMLS CUI [1]
- C0009488
Description
infection
Type de données
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
infection
Type de données
boolean
Alias
- UMLS CUI [1]
- C0009450
Description
pregnant or breastfeeding
Type de données
boolean
Alias
- UMLS CUI [1]
- C0549206
- UMLS CUI [2]
- C0006147
Description
significant concurrent disease, illness, or psychiatric disorder that would compromise patient safety or compliance, interfere with consent, study participation, follow up, or interpretation
Type de données
boolean
Alias
- UMLS CUI [1]
- C0021430
- UMLS CUI [2]
- C0439801
- UMLS CUI [3]
- C0009488
Similar models
Eligibility Acute Lymphoblastic Leukemia NCT00983528
- StudyEvent: Eligibility
C0277556 (UMLS CUI [2])
C1848676 (UMLS CUI [2])
C0162340 (UMLS CUI [2])
C1522449 (UMLS CUI [2])
C0021083 (UMLS CUI [3])
C3714787 (UMLS CUI [2])
C0039590 (UMLS CUI [3])
C0006147 (UMLS CUI [2])
C0439801 (UMLS CUI [2])
C0009488 (UMLS CUI [3])